A training company that teaches medical providers how to perform cosmetic injections has partnered with the UNC School of Nursing in Chapel Hill to offer hands-on instruction in Botox and dermal ...

The FDA is expected to decide on treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity.

A service tailored to people with workplace-based insurance coverage represents a new way for Lilly to bypass insurers and expand use of its popular obesity shot.

Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing ...

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

An increasing number of women who use estrogen patches to help deal with perimenopause and menopause symptoms have been ...

In our news wrap Thursday, a group of states is suing the Trump administration over its planned 15% global tariff, Defense Secretary Pete Hegseth told Latin American countries to step up their fight ...

The U.S. Food and Drug Administration on ‌Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making ...

Another front opens in the battle between hospitals and drugmakers over the 340B drug discount program Good afternoon, and thanks for checking in with the Health Brief newsletter. Please send any tips ...

White House official Stephen Miller told a ​gathering of Latin American military leaders on Thursday that drug cartels can ...

President Donald Trump's administration is expanding its crackdown on state Medicaid programs to New York, launching a fraud probe in the state.

LOS ANGELES, CA - March 04, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has published a ...